cupric sulfide has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Liu, X; Wu, L; Wu, M; Zeng, Y; Zhang, D; Zheng, A | 1 |
| Cai, Z; Li, J; Liao, N; Liu, G; Liu, J; Liu, X; Wei, Z; Wu, L; Wu, M; Yang, H; Zhang, D; Zhang, X; Zheng, A | 1 |
2 other study(ies) available for cupric sulfide and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.
Topics: Adsorption; Carcinoma, Hepatocellular; Cell Death; Cell Survival; Copper; Doxorubicin; Drug Liberation; Hep G2 Cells; Humans; Hyperthermia, Induced; Lasers; Liver Neoplasms; Nanoparticles; Phototherapy; Polyethylene Glycols; Porosity; Silicon Dioxide; Spectroscopy, Near-Infrared; Temperature | 2015 |
Smart Cu(II)-aptamer complexes based gold nanoplatform for tumor micro-environment triggered programmable intracellular prodrug release, photodynamic treatment and aggregation induced photothermal therapy of hepatocellular carcinoma.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Aptamers, Nucleotide; Carcinoma, Hepatocellular; Copper; Disease Models, Animal; Drug Carriers; Gold; Hep G2 Cells; Heterografts; Humans; Hyperthermia, Induced; Hypoxia; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Photochemotherapy; Prodrugs; Treatment Outcome | 2017 |